Nanotechnology in Cancer Diagnosis and Therapy

Prasad, Minakshi; Buragohain, Lukumoni; Ghosh, Mayukh; Kumar, Rajesh

doi:10.1007/978-981-16-5422-0_120

Minakshi Prasad²,
Lukumoni Buragohain³,
Mayukh Ghosh^4,6 &
…
Rajesh Kumar⁵

62 Accesses

Abstract

Earliest precise diagnosis and targeted therapy underlines the efficiency of successful cancer management. Conventional diagnostics are usually dependent on phenotypic expression of cancer signatures which often effects into delayed detection leading to poor prognosis. Traditional therapeutics frequently lacks precise targeting leading to sub-optimal drug concentration as well as off-target systemic side effects. Nano-intervention delivers in both the aspects: integration of advanced imaging modalities with site-specific targeting of nano-imaging agents can improve the sensitivity and specificity of cancer detection along with advent of diverse nanoparticle-based biosensors extends the scope for rapid and point-of-care diagnosis. Moreover, multifunctional nanoparticles facilitate simultaneous diagnosis and therapies of cancers in one go. Nanoparticle-based drug delivery systems with spatio-temporally controlled release mechanism facilitate targeted payload conveyance at the tumor sites with prolongs maintenance of adequate drug concentration to curtail general toxicity of the chemotherapeutics. Furthermore, it augments the pharmacokinetic properties of the drugs by improving the penetration, distribution and bioavailability of the therapeutic agents, even occasionally fortifying with synergistic effects. Premature drug release, fast enzymatic degradation, and rapid clearance can also be avoided by exploiting nano-encapsulation and stimuli-responsive nanoparticle-based drug delivery systems. Cancer immunotherapy has also gained significant attention in current scenario which mostly relies upon nanoparticle-based biological and vaccine delivery systems along with introduction of nano-adjuvants as component of nano-vaccines to enhance the immunogenicity and protection against cancers. Thus nanotechnology has the potential to empower the arsenal against cancer by diverse means; however, it faces some inherent challenges such as potential toxicity of nanomaterials, stringent regulatory issues delaying smooth and timely clinical transition of nano-drugs, lack of established international standards and protocols, redundant nanoparticle applications, and associated issues regarding the intellectual property rights, etc. Diligent focused efforts from all the stakeholders globally is paying-off as significant improvement have been observed in the “bench to beside” transition of the nano-formulations and newer candidates are reaching the market at regular basis currently which ensures a bright future prospect of nanotechnology in cancer arena.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

Al-Jamal KT, Al-Jamal WT, Wang JT, Rubio N, Buddle J, Gathercole D et al (2013) Cationic poly-L-lysine dendrimer complexes doxorubicin and delays tumor growth in vitro and in vivo. ACS Nano 7:1905–1917. https://doi.org/10.1021/nn305860k
Article CAS Google Scholar
Anselmo AC, Mitragotri S (2019) Nanoparticles in the clinic: an update. Bioeng Transl Med 4:e10143. https://doi.org/10.1002/btm2.10143
Article Google Scholar
Bae KH, Choi SH, Park SY, Lee Y, Park TG (2006) Thermosensitive pluronic micelles stabilized by shell cross-linking with gold nanoparticles. Langmuir 22:6380–6384. https://doi.org/10.1021/la0606704
Article CAS Google Scholar
Beltrán-Gracia E, López-Camacho A, Higuera-Ciapara I, Velázquez-Fernández JB, Vallejo-Cardona AA (2019) Nanomedicine review: clinical developments in liposomal applications. Cancer Nano 10:11. https://doi.org/10.1186/s12645-019-0055-y
Article CAS Google Scholar
Bhardwaj V, Kaushik A, Khatib ZM, Nair M, McGoron AJ (2019) Recalcitrant issues and new frontiers in nano-pharmacology. Front Pharmacol 10:1369. https://doi.org/10.3389/fphar.2019.01369
Article Google Scholar
Bobo D, Robinson KJ, Islam J, Thurecht KJ, Corrie SR (2016) Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharm Res 33:2373–2387. https://doi.org/10.1007/s11095-016-1958-5
Article CAS Google Scholar
Cai H, Shukla S, Steinmetz NF (2020) The antitumor efficacy of CpG oligonucleotides is improved by encapsulation in plant virus-like particles. Adv Funct Mater 1908743. https://doi.org/10.1002/adfm.201908743
Chen Q, Tong S, Dewhirst MW, Yuan F (2004) Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome. Mol Cancer Ther 3:1311–1317
Article CAS Google Scholar
Chen Q, Wang C, Zhang X, Chen G, Hu Q, Li H et al (2019) In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment. Nat Nanotechnol 14:89–97. https://doi.org/10.1038/s41565-018-0319-4
Article CAS Google Scholar
Chung YH, Cai H, Steinmetz NF (2020) Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications. Adv Drug Deliv Rev. https://doi.org/10.1016/j.addr.2020.06.024
De Cock I, Lajoinie G, Versluis M, De Smedt SC, Lentacker I (2016) Sonoprinting and the importance of microbubble loading for the ultrasound mediated cellular delivery of nanoparticles. Biomaterials 83:294–307. https://doi.org/10.1016/j.biomaterials.2016.01.022
Article CAS Google Scholar
Deelman LE, Declèves AE, Rychak JJ, Sharma K (2010) Targeted renal therapies through microbubbles and ultrasound. Adv Drug Deliv Rev 62:1369–1377. https://doi.org/10.1016/j.addr.2010.10.002
Article CAS Google Scholar
Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M et al (1998) Photodynamic therapy. J Natl Cancer Inst 90:889–905. https://doi.org/10.1093/jnci/90.12.889
Article CAS Google Scholar
Ganta S, Iyer A, Amiji M (2010) Multifunctional stimuli–responsive nanoparticles for targeted delivery of small and macromolecular therapeutics. Targeted Delivery Small Macromolecular Drugs 555–585. https://doi.org/10.1201/9781420087734-c20
Gao S, Zhang L, Wang G, Yang K, Chen M, Tian et al (2016) Hybrid graphene/Au activatable theranostic agent for multimodalities imaging guided enhanced photothermal therapy. Biomaterials 79:36–45. https://doi.org/10.1016/j.biomaterials.2015.11.041
Article CAS Google Scholar
Garnett MC (2001) Targeted drug conjugates: principles and progress. Adv Drug Deliv Rev 53:171–216. https://doi.org/10.1016/s0169-409x(01)00227-7
Article CAS Google Scholar
Gmeiner WH, Ghosh S (2015) Nanotechnology for cancer treatment. Nanotechnol Rev 3:111–122. https://doi.org/10.1515/ntrev-2013-0013
Article CAS Google Scholar
Gupta AK, Naregalkar RR, Vaidya VD, Gupta M (2007) Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine 2:23–39. https://doi.org/10.2217/17435889.2.1.23
Article CAS Google Scholar
Hagan CT 4th, Medik YB, Wang AZ (2018) Nanotechnology approaches to improving cancer immunotherapy. Adv Cancer Res 139:35–56. https://doi.org/10.1016/bs.acr.2018.05.003
Article CAS Google Scholar
Han HD, Shin BC, Choi HS (2006) Doxorubicin-encapsulated thermosensitive liposomes modified with poly(N-isopropylacrylamide-co-acrylamide): drug release behavior and stability in the presence of serum. Eur J Pharm Biopharm 62:110–116. https://doi.org/10.1016/j.ejpb.2005.07.006
Article CAS Google Scholar
Hassan HAFM, Smyth L, Wang JTW, Costa PM, Ratnasothy K, Diebold SS et al (2016) Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy. Biomaterials 104:310–322. https://doi.org/10.1016/j.biomaterials.2016.07.005
Article CAS Google Scholar
Jhaveri A, Deshpande P, Torchilin V (2014) Stimuli-sensitive nanopreparations for combination cancer therapy. J Control Release 190:352–370. https://doi.org/10.1016/j.jconrel.2014.05.002
Article CAS Google Scholar
Ji H, Sun H, Qu X (2016) Antibacterial applications of graphene-based nanomaterials: recent achievements and challenges. Adv Drug Deliv Rev 105:176–189. https://doi.org/10.1016/j.addr.2016.04.009
Article CAS Google Scholar
Jiang D, Gao X, Kang T, Feng X, Yao J, Yang M et al (2016) Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer. Nanoscale 8:3100–3118. https://doi.org/10.1039/c5nr07724a
Article CAS Google Scholar
Johnson RP, Jeong YI, John JV, Chung CW, Kang DH, Selvaraj M et al (2013) Dual stimuli-responsive poly(N-isopropylacrylamide)-b-poly(L-histidine) chimeric materials for the controlled delivery of doxorubicin into liver carcinoma. Biomacromolecules 14:1434–1443. https://doi.org/10.1021/bm400089m
Article CAS Google Scholar
Kaminskas LM, Kelly BD, McLeod VM, Boyd BJ, Krippner GY, Williams ED et al (2009) Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-l-lysine dendrimers. Mol Pharm 6:1190–1204. https://doi.org/10.1021/mp900049a
Article CAS Google Scholar
Kim KY (2007) Nanotechnology platforms and physiological challenges for cancer therapeutics. Nanomedicine 3:103–110. https://doi.org/10.1016/j.nano.2006.12.002
Article CAS Google Scholar
Kim SY, Ha JC, Lee YM (2000) Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres. II. Thermo-responsive drug release behaviors. J Control Release 65:345–358. https://doi.org/10.1016/s0168-3659(99)00207-2
Article CAS Google Scholar
Kim J, Santos OA, Park JH (2014) Selective photosensitizer delivery into plasma membrane for effective photodynamic therapy. J Control Release 191:98–104. https://doi.org/10.1016/j.jconrel.2014.05.049
Article CAS Google Scholar
Kim H, Chung K, Lee S, Kim DH, Lee H (2016) Near-infrared light-responsive nanomaterials for cancer theranostics. WIREs Nanomed Nanobiotechnol 8:23–45. https://doi.org/10.1002/wnan.1347
Article CAS Google Scholar
Kou L, Sun J, Zhai Y, He Z (2013) The endocytosis and intracellular fate of nanomedicines: implication for rational design. Asian J Pharmaceut Sci 8:1–10. https://doi.org/10.1016/j.ajps.2013.07.001
Article CAS Google Scholar
Kranz LM, Diken M, Haas H, Kreiter S, Loquai C, Reuter KC et al (2016) Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature 534:396–401. https://doi.org/10.1038/nature18300
Article CAS Google Scholar
Krauss AC, Gao X, Li L, Manning ML, Patel P, Fu W et al (2019) FDA approval summary: (Daunorubicin and Cytarabine) liposome for injection for the treatment of adults with high-risk acute myeloid leukemia. Clin Cancer Res 25:2685–2690. https://doi.org/10.1158/1078-0432.CCR-18-2990
Article CAS Google Scholar
Kuai R, Ochyl LJ, Bahjat KS, Schwendeman A, Moon JJ (2017) Designer vaccine nanodiscs for personalized cancer immunotherapy. Nat Mater 16:489–496. https://doi.org/10.1038/nmat4822
Article CAS Google Scholar
Kumari P, Ghosh B, Biswas S (2016) Nanocarriers for cancer-targeted drug delivery. J Drug Target 24:179–191. https://doi.org/10.3109/1061186X.2015.1051049
Article CAS Google Scholar
Lee J, Min HS, You DG, Kim K, Kwon IC, Rhim T et al (2016) Theranostic gas-generating nanoparticles for targeted ultrasound imaging and treatment of neuroblastoma. J Control Release 223:197–206. https://doi.org/10.1016/j.jconrel.2015.12.051
Article CAS Google Scholar
Lentacker I, Geers B, Demeester J, De Smedt SC, Sanders NN (2010) Tumor cell killing efficiency of doxorubicin loaded microbubbles after ultrasound exposure. J Control Release 148:e113–e114. https://doi.org/10.1016/j.jconrel.2010.07.085
Article CAS Google Scholar
Li Z, Tan S, Li S, Shen Q, Wang K (2017) Cancer drug delivery in the nano era: an overview and perspectives (review). Oncol Rep 38:611–624. https://doi.org/10.3892/or.2017.5718
Article CAS Google Scholar
Li Y, Ayala-Orozco C, Rauta PR, Krishnan S (2019) The application of nanotechnology in enhancing immunotherapy for cancer treatment: current effects and perspective. Nanoscale 11:17157–17178. https://doi.org/10.1039/c9nr05371a
Article CAS Google Scholar
Liang R, Xie J, Li J, Wang K, Liu L, Gao Y et al (2017) Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response. Biomaterials 149:41–50. https://doi.org/10.1016/j.biomaterials.2017.09.029
Article CAS Google Scholar
Lovell JF, Jin CS, Huynh E, Jin H, Kim C, Rubinstein JL et al (2011) Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater 10:324–332. https://doi.org/10.1038/nmat2986
Article CAS Google Scholar
Luo M, Wang H, Wang Z, Cai H, Lu Z, Li Y et al (2017) A STING-activating nanovaccine for cancer immunotherapy. Nat Nanotechnol 12:648–654. https://doi.org/10.1038/nnano.2017.52
Article CAS Google Scholar
Maiti D, Tong X, Mou X, Yang K (2019) Carbon-based nanomaterials for biomedical applications: a recent study. Front Pharmacol 9:1–16. https://doi.org/10.3389/fphar.2018.01401
Article CAS Google Scholar
Malik N, Evagorou EG, Duncan R (1999) Dendrimer-platinate: a novel approach to cancer chemotherapy. Anti-Cancer Drugs 10:767–776
Article CAS Google Scholar
Martinelli C, Pucci C, Ciofani G (2019) Nanostructured carriers as innovative tools for cancer diagnosis and therapy. APL Bioeng 3:011502. https://doi.org/10.1063/1.5079943
Article CAS Google Scholar
Meyer DE, Shin BC, Kong GA, Dewhirst MW, Chilkoti A (2001) Drug targeting using thermally responsive polymers and local hyperthermia. J Control Release 74:213–224. https://doi.org/10.1016/s0168-3659(01)00319-4
Article CAS Google Scholar
Mi Y, Smith CC, Yang F, Qi Y, Roche KC, Serody JS et al (2018) A dual immunotherapy nanoparticle improves T-cell activation and cancer immunotherapy. Adv Mater e1706098. https://doi.org/10.1002/adma.201706098
Miao L, Li L, Huang Y, Delcassian D, Chahal J, Han J et al (2019) Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation. Nat Biotechnol 37:1174–1185. https://doi.org/10.1038/s41587-019-0247-3
Article CAS Google Scholar
Panahi Y, Farshbaf M, Mohammad Hosseini M, Mirahadi M, Khalilov R, Saghfi S et al (2017) Recent advances on liposomal nanoparticles: synthesis, characterization and biomedical applications. Artif Cells Nanomed Biotechnol 45:788–799. https://doi.org/10.1080/21691401.2017.1282496
Article Google Scholar
Park J-H, von Maltzahn G, Xu MJ, Fogal V, Kotamraju VR, Ruoslahti E et al (2010) Cooperative nanomaterial system to sensitize, target, and treat tumors. Proc Natl Acad Sci USA 107:981–986. https://doi.org/10.1073/pnas.0909565107
Article CAS Google Scholar
Park W, Heo Y, Han DK (2018) New opportunities for nanoparticles in cancer immunotherapy. Biomater Res 22:24. https://doi.org/10.1186/s40824-018-0133-y
Article CAS Google Scholar
Parvanian S, Mostafavi SM, Aghashiri M (2017) Multifunctional nanoparticle developments in cancer diagnosis and treatment. Sens Bio-Sens Res 13:81–87. https://doi.org/10.1016/j.sbsr.2016.08.002
Article Google Scholar
Patil Y, Amitay Y, Ohana P, Shmeeda H, Gabizon A (2016) Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: intracellular activation and enhanced cytotoxicity. J Control Release 225:87–95. https://doi.org/10.1016/j.jconrel.2016.01.039
Article CAS Google Scholar
Ponce AM, Vujaskovic Z, Yuan F, Needham D, Dewhirst MW (2006) Hyperthermia mediated liposomal drug delivery. Int J Hyperth 22:205–213. https://doi.org/10.1080/02656730600582956
Article CAS Google Scholar
Prasad M, Kumar R, Buragohain L, Kumari A, Ghosh M (2021) Organoid technology: a reliable developmental biology tool for organ-specific nanotoxicity evaluation. Front Cell Dev Biol 9:696668. https://doi.org/10.3389/fcell.2021.696668
Article Google Scholar
Sanchez C, Belleville P, Popall M, Nicole L (2011) Applications of advanced hybrid organic-inorganic nanomaterials: from laboratory to market. Chem Soc Rev 40(2):696–753. https://doi.org/10.1039/c0cs00136h
Article CAS Google Scholar
Schroeder A, Honen R, Turjeman K, Gabizon A, Kost J, Barenholz Y (2009) Ultrasound triggered release of cisplatin from liposomes in murine tumors. J Control Release 137(1):63–68. https://doi.org/10.1016/j.jconrel.2009.03.007
Article CAS Google Scholar
Shapira A, Livney YD, Broxterman HJ, Assaraf YG (2011) Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. Drug Resist Updat 14:150–163. https://doi.org/10.1016/j.drup.2011.01.003
Article CAS Google Scholar
Steinmetz NF (2010) Viral nanoparticles as platforms for next-generation therapeutics and imaging devices. Nanomedicine 6:634–641. https://doi.org/10.1016/j.nano.2010.04.005
Article CAS Google Scholar
Tian Q, Tang M, Sun Y, Zou R, Chen Z, Zhu M et al (2011) Hydrophilic flower-like CuS superstructures as an efficient 980 nm laser-driven photothermal agent for ablation of cancer cells. Adv Mater 23:3542–3547. https://doi.org/10.1002/adma.201101295
Article CAS Google Scholar
Tran S, De Giovanni PJ, Piel B, Rai P (2017) Cancer nanomedicine: a review of recent success in drug delivery. Clin Transl Med 6:44. https://doi.org/10.1186/s40169-017-0175-0
Article Google Scholar
Turk M, Dinçer S, Pişkin E (2007) Smart and cationic poly(NIPA)/PEI block copolymers as non-viral vectors: in vitro and in vivo transfection studies. J Tissue Eng Regen Med 1:377–388. https://doi.org/10.1002/term.47
Article CAS Google Scholar
Van Zuylen L, Verweij J, Sparreboom A (2001) Role of formulation vehicles in taxane pharmacology. Investig New Drugs 19:125–141. https://doi.org/10.1023/a:1010618632738
Article Google Scholar
Vasir JK, Reddy MK, Labhasetwar VD (2005) Nanosystems in drug targeting: opportunities and challenges. Curr Nanosci 1:47–64. https://doi.org/10.2174/1573413052953110
Article CAS Google Scholar
Wang YC, Wang F, Sun TM, Wang J (2011) Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells. Bioconjug Chem 22(10):1939–1945. https://doi.org/10.1021/bc200139n
Article CAS Google Scholar
Wang L, Shi C, Wright FA, Guo D, Wang X, Wang D et al (2017) Multifunctional Telodendrimer nanocarriers restore synergy of Bortezomib and doxorubicin in ovarian cancer treatment. Cancer Res 77:3293–3305. https://doi.org/10.1158/0008-5472.CAN-16-3119
Article CAS Google Scholar
Wang H, Tang Y, Fang Y, Zhang M, Wang H, He Z et al (2019) Reprogramming tumor immune microenvironment (TIME) and metabolism via biomimetic targeting codelivery of Shikonin/JQ1. Nano Lett 19:2935–2944. https://doi.org/10.1021/acs.nanolett.9b00021
Article CAS Google Scholar
World Health Organization (2018). https://www.who.int/news-room/fact-sheets/detail/cancer
World Health Organization (2020). https://www.who.int/mediacentre/news/releases/2003/pr27/en/
Wu S, Powers S, Zhu W, Hannun YA (2016) Substantial contribution of extrinsic risk factors to cancer development. Nature 529(7584):43–47. https://doi.org/10.1038/nature16166
Article CAS Google Scholar
Yadav PK, Gupta SK, Kumar S, Ghosh M, Yadav BS, Kumar D et al (2020) IL-18 immunoadjuvanted xenogeneic canine MMP-7 DNA vaccine overcomes immune tolerance and suppresses the growth of murine mammary tumor. Int Immunopharmacol 82:106370. https://doi.org/10.1016/j.intimp.2020.106370
Article CAS Google Scholar
Yatvin MB, Weinstein JN, Dennis WH, Blumenthal R (1978) Design of liposomes for enhanced local release of drugs by hyperthermia. Science 202:1290–1293. https://doi.org/10.1126/science.364652
Article CAS Google Scholar
Yoshida R, Uchida K, Kaneko Y, Sakai K, Kikuchi A, Sakurai Y et al (1995) Comb-type grafted hydrogels with rapid deswelling response to temperature changes. Nature 374:240–242. https://doi.org/10.1038/374240a0
Article CAS Google Scholar
Yu GT, Rao L, Wu H, Yang LL, Bu LL, Deng WW et al (2018) Myeloid-derived suppressor cell membrane-coated magnetic nanoparticles for cancer theranostics by inducing macrophage polarization and synergizing immunogenic cell death. Adv Funct Mater 28:1801389. https://doi.org/10.1002/adfm.201801389
Article CAS Google Scholar
Zha Z, Yue X, Ren Q, Dai Z (2013) Uniform polypyrrole nanoparticles with high photothermal conversion efficiency for photothermal ablation of cancer cells. Adv Mater 25:777–782. https://doi.org/10.1002/adma.201202211
Article CAS Google Scholar

Download references

Author information

Authors and Affiliations

Department of Animal Biotechnology, Lala Lajpat Rai University of Veterinary and Animal Sciences, Hisar, India
Minakshi Prasad
Department of Animal Biotechnology, College of Veterinary Science, Assam Agricultural University, Guwahati, Assam, India
Lukumoni Buragohain
Department of Veterinary Physiology and Biochemistry, RGSC, Banaras Hindu University, Mirzapur, Uttar Pradesh, India
Mayukh Ghosh
Department of Veterinary Physiology and Biochemistry, Lala Lajpat Rai University of Veterinary and Animal Sciences, Hisar, India
Rajesh Kumar
Faculty of Veterinary and Animal Sciences, Rajiv Gandhi South Campus, Banara Hindu University, Mirzapur, Uttar Pradesh, India
Mayukh Ghosh

Authors

Minakshi Prasad
View author publications
You can also search for this author in PubMed Google Scholar
Lukumoni Buragohain
View author publications
You can also search for this author in PubMed Google Scholar
Mayukh Ghosh
View author publications
You can also search for this author in PubMed Google Scholar
Rajesh Kumar
View author publications
You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

Department of Biochemistry and Biophysics, University of Kalyani, Kalyani, West Bengal, India
Sajal Chakraborti

Section Editor information

Department of Chemistry and Biochemistry, University of Texas, El Paso, Texas, USA
Mahesh Narayan
School of Biotechnology, KIIT Deemed to be University, Institute of Eminence, Bhubaneswar, India
Gopal C. Kundu
Department of Biotechnology and Medical Engineering, National Institute of Technology Rourkela, Rourkela-, Odisha, India
Subhankar Paul
Institute of Bioinformatics and Biotechnology, SavitribaiPhule Pune University, Pune, Maharastra, India
Tuli Dey
Department of Animal Biotechnology, Lala lajpat Rai University of Veterinary and Animal Sciences, Hisar, Haryana, India
Minakshi Prasad Ph.D

Rights and permissions

Reprints and permissions

Copyright information

About this entry

Cite this entry

Prasad, M., Buragohain, L., Ghosh, M., Kumar, R. (2022). Nanotechnology in Cancer Diagnosis and Therapy. In: Chakraborti, S. (eds) Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Springer, Singapore. https://doi.org/10.1007/978-981-16-5422-0_120

Download citation

DOI: https://doi.org/10.1007/978-981-16-5422-0_120
Published: 29 September 2022
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-5421-3
Online ISBN: 978-981-16-5422-0
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics